Comparative study of calcified changes in aortic valvular diseases

Journal of Nippon Medical School

Volumn 75, Issue 3, 2008, Pages 138-145

  Togashi, Mayuko ^a   Tamura, Koichi ^b   Masuda, Yukinari ^a   Fukuda, Yuh ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b TOKYO TEISHIN HOSPITAL   (Japan)

Author keywords

Aortic valve calcification; Aortic valve stenosis; Collagen fiber; Elastic fiber

Indexed keywords

CALCIUM; COLLAGEN FIBRIL;

ADULT; AGED; AORTA ATHEROSCLEROSIS; AORTA VALVE DISEASE; ARTICLE; BICUSPID AORTIC VALVE DISEASE; CALCIFICATION; CONNECTIVE TISSUE; DEGENERATIVE AORTIC VALVE DISEASE; ELECTRON MICROSCOPY; FEMALE; HEART VALVE REPLACEMENT; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; RHEUMATIC AORTIC VALVE DISEASE; SCLEROSIS; ULTRASTRUCTURE;

ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; CALCINOSIS; FEMALE; HUMANS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED;

EID: 45349100486     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.75.138     Document Type: Article

References (31)

1. Yamamoto K, Hayashi J, Miyamura H, Eguchi S, Ishihara N: A historical analysis of heart valve lesions determined by macroscopic and histological examination at the time of valve replacement for valvular heart diseases. Heart 1992; 24: 917-924.
2. Fujiwara T, Marukami T, Inada H, et al.: The etiology of aortic valve disease-A study of 160 surgical cases. Heart 1999; 31: 145-148.
3. Kajikawa K, Yamaguchi T, Katsuda S, Miwa A: An improved electron stain for elastic fiber using tannic acid. J Electron Microsc 1975; 24: 287-289.
4. Tamura K, Fukuda Y, Ishizaki M, Masuda Y, Yamanaka N, Ferrans VJ: Abnormalities in elastic fibers and other connective-tissue components of floppy mitral valve. Am Heart J 1995; 129: 1149-1158.
5. Paegle RD: Ultrastructure of calcium deposits in atherosclerotic human aortas. J Ultrastructure Research 1969; 26: 412-423.
6. Kawakami T, Nakamura C, Hasegawa H, et al.: Ultrastructure study of calcinosis universalis with dermatomyositis. J Cutan Pathol 1986; 13: 135-143.
7. Ferrans VJ, Spray TL, Billingham ME, Roberts WC: Structural changes in glutaraldehyde-treated porcine heterografts used as substitute cardiac valves. Trransmission and scanning electron microscopic observations in 12 patients. Am J Cardiol 1979; 41: 1159-1184.
8. Tamura K, Jones M, Yamada I, Ferrans VJ: A comparison of failure modes of glutaraldehyde-treated versus antibiotec-preserved mitral valve allografts implanted in sheep. J Thorac Cardiovasc Surg 1995; 110: 224-238.
9. Shioi A: Mechanism of vascular calcification. THE BONE 2005; 19: 29-34.
10. Schoen FJ, Levy RJ: Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res 1999; 47: 439-465.
11. Schoen FJ, Levy RJ: Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005; 79: 1072-1080.
12. Józsa L, Réffy A, Balint BJ, Järvinen M, Kvist M: Ischemic-hypoxic changes in muscles with tendon injuries (author's transl). Magy Traumatol Orthop Helyreallito Seb 1981; 24: 218-226.
13. Danis A: Soft tissue ossification: mechanism. Bull Mem Acad R Med Belg 1992; 147: 298-306.
14. Fartasch M, Haneke E, Hornstein OP: Mineralization of collagen and elastic fibers in superficial dystrophic cutaneous calcification: an ultrastructural study. Dermatologica 1990; 181: 187-192.
15. Cannon RO, Butany JW, Mcmanus BM, Kravitz AB, Bolli R, Ferrans VJ: Early degradation of collagen after acute myocardial infarction in the rat. Am J Cardiol 1983; 52: 390-395.
16. Waggett AD, Kielty CM, Shuttleworth CA: Microfibrillar elements in the synovial joint: presence of type IV collagen and fibrillin-containing microfibrils. Ann Rheum Dis 1993; 52: 449-453.
17. Daamen WF, Nillesen ST, Hafmans T, Veerkamp JH, Luyn MJA, Kuppevelt THA: Tissue response of defined collagen-elastin scaffolds in young and adult rats with special attention to calcification. Biomaterials 2005; 26: 81-92.
18. Hoff HF, Bradley WA, Heideman CL, Gaubatz JW, Karagas MD, Gotto AM: Characterization of low density lipoprotein-like particle in the human aorta from grossly normal and atherosclerotic regions. Biochim Biophys Acta 1979; 573: 361-374.
19. Walton KW, Williamson N, Johnson AG: The pathogenesis of atherosclerosis of the mitral and aortic valves. J Pathol 1970; 101: 205-220.
20. Togashi M, Tamura K, Madenokouji N, Fukuda Y, Sugisaki Y: Comparative study on the sclerotic changes of cardiac valve and blood vessel. J Nippon Med Sch 2003; 70: 496-508.
21. Garg V, Muth AN, Ransom JF, et al.: Mutations in NOTCH1 cause aortic valve disease. Nature 2005; 437: 270-274.
22. Thubrikar MJ, Deck JD, Aouad J, Chen JM: Intramural stress as a causative factor in atherosclerotic lesions of the aortic valve. Atherosclerosis 1985; 55: 299-311.
23. Ross R: A problem of the biology of arterial wall cells and their interactions with blood components. Atherosclerosis 1981; 1: 293-311.
24. Ross R: The pathogenesis of atherosclerosis-an update. New Engl J Med 1986; 314: 488-500.
25. Yener N, Oktar GL, Erer D, Yardimci MM, Yener A: Bicuspid aortic valve. Ann Thorac Cardiovasc Surg 2002; 8: 264-267.
26. Fenoglio JJ, Mcallister HA, Decastro CM, Davia JE, Cheitlin MD: Congenital bicuspid aortic valve after age 20. Am J Cardiol 1977; 39: 164-169.
27. Roberts WC: The congenitally bicuspid aortic valve. A study of 85 autopsy cases. Am J Cardiol 1970; 26: 72-83.
28. Lilly LS, Kawana M, Kawana Y: Pathophysiology of heart disease. In A collaborative project of medical students and faculty, 2nd ed., c1998 2000; pp 194, Medical Science International, Tokyo.
29. Robicsek F, Thubrikar MJ, Cook JW, Fowler B: The congenitally bicuspid aortic valve: how does it function? Why does it fail? Ann Thorac Surg 2004; 77: 177-185.
30. Ward C: Clinical significance of the bicuspid aortic valve. Heart 2000; 83: 81-85.
31. Sabset HY, Edwards WD, Tazelaar HD, Daly RC: Congenitally bicuspid aortic valves: a surgical pathology study of 542 cases (1991 Through 1996) and a literature review of 2,715 additional cases. Mayo Clin Proc 1999; 74: 14-26.